Herpes Virus Infections
Virology is a rapidly advancing science which is now beginning to pay clear dividends in terms of our understanding of the relationship betwen viruses and their host cells and in providing more rational ways of developing major therapeutic advances. Since the first viruses to be readily tackled by chemotherapy are members of the Herpesviridae this chapter will confine itself to a discussion of the biology of this fascinating group and our attempts at the therapeutic control of the human diseases these cause.
KeywordsInfluenza Interferon Thymidine Nash Encephalitis
Unable to display preview. Download preview PDF.
- Brigden D, Fowle A, Rosling A (1980) Acyclovir, a new antiherpetic drug: early experience in man with systemically administered drug. In: Collier LH (ed) Developments in antiviral therapy. Academic, Oxford, pp 53–62Google Scholar
- Dekker C, Ellis MN, McLaren C, Hunter G, Rogers J, Barry DW (1983) Virus resistance in clinical practice. J Antimicrob Chemother 12B:137–152Google Scholar
- Juel-Jensen BE, MacCullum FO (1972) Herpes simplex, varicella and zoster. Heinemann, LondonGoogle Scholar
- Kinghorn GR, Barton IG, Potter CW, Fiddian AP (1983) Oral acyclovir prophylaxis of recurrent genital herpes (Abstr 185). 5th International Meeting of the International Society for STD Research, SeattleGoogle Scholar
- Prentice HG (1983) Use of acyclovir for prophylaxis of herpes infections in severely immunocompromised patients. J Antimicrob Chemother 12B: 153–159Google Scholar
- Straus SE; Takiff HE, Seidlin M, Bachrach S, Lininger L, di Giovanna JJ, Western KA et al. (1984) Suppression of frequently recurring genital herpes: a placebo-controlled double-blind trial of oral acyclovir. J Med 310:1545–1550Google Scholar
- Whitley RJ, Alford CA (1981) Parenteral antiviral chemotherapy of human herpesviruses. In: Nahmias AJ, Dowdle WR, Shinazi RF (eds) The human herpesviruses. Elsevier, New York, pp 478–490Google Scholar